CONTACT
中文
中文

News

  • PUBLIC NOTICE

USTAR MultNAT MTB/RIF Assay officially approved by the China National Medical Products Administration (NMPA)!

A "Global Solution" for innovating the diagnosis of drug-resistant tuberculosis.
10.09.2025
  • BUSINESS MOVEMENT

On August 15, 2025, Ustar Biotech and University Indonesia officially signed a Memorandum of Understanding (MoU) in Jakarta

University Indonesia, was founded in 1849. It is the oldest higher education institution in Indonesia and a world-leading research university
10.09.2025
  • BUSINESS MOVEMENT

Ustar Biotechnology’s Monkeypox Virus Assays Receive WHO Emergency Use Listing (EUL).

The first cerctificate in China, which passed WHO Emergency Use Listing (EUL) approval for the Ustars’ Molecular POC Monkeypox Virus (MPXV ) Assay
10.09.2025
Ustar Biotechnologies (Hangzhou) Ltd. 
(Headquarters)

Add: 6/F, Building 2, 611 Dongguan Road, Binjiang District, Hangzhou, Zhejiang, P.R. China

Zip: 310053

Email: sales@bioustar.com   

Tel: +86-571-88939358 

Copyright Ustar Biotechnologies 2025. All rights reserved
浙ICP备20029265号
Privacy Policy
Terms of Use
Reagent

MultNAT

PortNAT

EasyNAT

Consumables

System

MultNAT

PortNAT

EasyNAT

Solution
For Primary Healthcare Settings
For Labs
For Hospitals
Public Health Solutions
STI Solutions
Respiratory Infection Solutions
Tuberculosis Solutions
Livestock Solutions
About us

Company Profile

R&D Strength

Social Responsibility

CONTACT